Böhringer et al., 2015 - Google Patents
Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltrationBöhringer et al., 2015
- Document ID
- 18065371637435524818
- Author
- Böhringer F
- Jankowski V
- Gajjala P
- Zidek W
- Jankowski J
- Publication year
- Publication venue
- ASAIO journal
External Links
Snippet
Protein-bound uremic retention solutes accumulate in patients suffering from chronic kidney disease, and the removal of these solutes by hemodialysis is hampered. Therefore, we developed a dialysis technique where the protein-bound uremic retention solutes are …
- 230000014759 maintenance of location 0 title abstract description 42
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Böhringer et al. | Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration | |
Madero et al. | Removal of protein-bound uremic toxins during hemodialysis using a binding competitor | |
Vanholder et al. | What is new in uremic toxicity? | |
Brettschneider et al. | Removal of protein‐bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique | |
Ronco et al. | Extracorporeal blood purification and organ support in the critically ill patient during COVID-19 pandemic: expert review and recommendation | |
Karvellas et al. | Current evidence for extracorporeal liver support systems in acute liver failure and acute-on-chronic liver failure | |
Meijers et al. | p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients | |
Vanholder et al. | A bench to bedside view of uremic toxins | |
Cozzolino et al. | Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study | |
Viaene et al. | Albumin is the main plasma binding protein for indoxyl sulfate and p‐cresyl sulfate | |
Tao et al. | Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study | |
Krieter et al. | B isphenol A in Chronic Kidney Disease | |
Raff et al. | New insights into uremic toxicity | |
Sen et al. | Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study | |
Meijers et al. | Removal of the uremic retention solute p‐cresol using fractionated plasma separation and adsorption | |
Stadlbauer et al. | Artificial liver support systems in the management of complications of cirrhosis | |
MacDonald et al. | Emerging role of extracorporeal support in acute and acute-on-chronic liver failure: recent developments | |
Nakae et al. | Selective plasma exchange with dialysis in patients with acute liver failure | |
Eloot et al. | Removal of water-soluble and protein-bound solutes with reversed mid-dilution versus post-dilution haemodiafiltration | |
Thammathiwat et al. | Super high‐flux hemodialysis provides comparable effectiveness with high‐volume postdilution online hemodiafiltration in removing protein‐bound and middle‐molecule uremic toxins: A prospective cross‐over randomized controlled trial | |
Voigt et al. | Retention of beneficial molecules and coagulation factors during haemodialysis and haemodiafiltration | |
Shi et al. | Improved dialysis removal of protein-bound uraemic toxins with a combined displacement and adsorption technique | |
Shi et al. | Effect of ionic strength, pH and chemical displacers on the percentage protein binding of protein-bound uremic toxins | |
Patzer et al. | Bound solute dialysis | |
Messer et al. | Middle-molecule clearance in CRRT: in vitro convection, diffusion and dialyzer area |